Perivascular nitric oxide delivery to saphenous vein grafts prevents graft stenosis after coronary artery bypass grafting: A novel sheep model

Cardiology

Volumn 118, Issue 1, 2011, Pages 8-15

  Abbasi, Kyomars ^a   Shalileh, Keivan ^a   Anvari, Maryam Sotudeh ^a   Rabbani, Shahram ^a   Mahdanian, Abolfazl ^a   Ahmadi, Seyed Hosein ^a   Moshtaghi, Naghmeh ^a   Movahedi, Namvar ^a   Karimi, Abbasali ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Coronary artery bypass grafting; Nitric oxide; Saphenous vein grafts; Stenosis

Indexed keywords

DIETHYLENETRIAMINE; NITRIC OXIDE DONOR; NITRITE;

ANGIOGRAPHY; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY BLOOD VESSEL; DRUG BLOOD LEVEL; DRUG EFFICACY; EWE; HEART PROTECTION; NONHUMAN; OUTCOME ASSESSMENT; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; SAPHENOUS VEIN GRAFT; SAPHENOUS VEIN GRAFT STENOSIS; SURGICAL TECHNIQUE; VEIN GRAFT DISEASE;

ANIMALS; CORONARY ARTERY BYPASS; ENDOTHELIUM-DEPENDENT RELAXING FACTORS; FEMALE; GRAFT OCCLUSION, VASCULAR; NITRIC OXIDE; NITRITES; PILOT PROJECTS; RANDOM ALLOCATION; SAPHENOUS VEIN; SHEEP; TRANSPLANTATION, AUTOLOGOUS;

EID: 79952358554     PISSN: 00086312     EISSN: None     Source Type: Journal    
DOI: 10.1159/000324316     Document Type: Article

References (36)

1. Harnek J, Zoucas E, Sjuve R, Arner A, Ekblad E, Schou H, Perez de Sá V, Sternam U: Local infusion of the nitric oxide donor SIN-1 after angioplasty. Effects on intimal hyperplasia in porcine coronary arteries. Acta Radiol 2003; 44: 395-402.
2. Favaloro RG: Saphenous vein graft in the surgical treatment of coronary artery disease. Operative technique. J Thorac Cardiovasc Surg 1969; 58: 178-185.
3. Rodés-Cabau J, Facta A, Larose E, DeLarochellière R, Déry JP, Nguyen CM, Roy L, Proulx G, Gleeton O, Barbeau G, Noël B, Rouleau J, Boudreault JR, Bertrand OF: Predictors of aorto-saphenous vein bypass narrowing late after coronary artery bypass grafting. Am J Cardiol 2007; 100: 640-645. (Pubitemid 47223143)
4. Wallitt EJ, Jevon M, Hornick PI: Therapeutics of vein graft intimal hyperplasia: 100 years on. Ann Thorac Surg 2007; 84: 317-323. (Pubitemid 46921110)
5. Klima T, Beard EF, Milam JD, Reul GJ Jr, Cooley DA: Atherosclerosis of aortocoronary saphenous vein bypass grafts. Cardiovasc Dis 1979; 6: 318-323. (Pubitemid 10239882)
6. Bourassa MG: Fate of venous grafts: the past, the present, and the future. J Am Coll Cardiol 1991; 17: 1081-1083.
7. Fitzgibbon GM, Kafka HO, Keach AJ, Keon WJ, Hooper GD, Burton JR: Coronary bypass graft fate and patient outcome: angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years. J Am Coll Cardiol 1996; 28: 616-626. (Pubitemid 26288642)
8. Lau GT, Ridley LJ, Bannon PG, Wong LA, Trieu J, Brieger DB, Lowe HC, Freedman BS, Kritharides L: Lumen loss in the first year in saphenous vein grafts is predominantly a result of negative remodeling of the whole vessel rather than a result of changes in wall thickness. Circulation 2006; 114;I435-I440. (Pubitemid 44297188)
9. Barner HB, Barnett MB: Fifteen- to twentyone- year angiographic assessment of internal thoracic artery as a bypass conduit. Ann Thorac Surg 1994; 57: 1526-1528. (Pubitemid 24216320)
10. Tarr FI, Sasvári M, Tarr M, Rácz R: Evidence of nitric oxide produced by the internal mammary artery graft in venous drainage of the recipient coronary artery. Ann Thorac Surg 2005; 80: 1728-1731. (Pubitemid 41464291)
11. Moncada S, Palmer RM, Higgs EA: Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991; 43: 109-142.
12. Vallance P, Chan N: Endothelial function and nitric oxide: clinical relevance. Heart 2001; 85: 342-350. (Pubitemid 32973574)
13. Yogo K, Shimokawa H, Funakoshi H, Kandabashi T, Miyata K, Okamoto S, Egashira K, Huang P, Akaike T, Takeshita A: Different vasculoprotective roles of NO synthase isoforms in vascular lesion formation in mice. Arterioscler Thromb Vasc Biol 2000; 20:E96-E100.
14. Vallance P, Collier J, Moncada S. Nitric oxide synthesized from L -arginine mediates endothelium- dependent dilatation in human veins in vivo. Cardiovasc Res 1989; 23: 1053-1057. (Pubitemid 20016627)
15. de Nigris F, Mancini FP, Balestrieri ML, Byrns R, Fiorito C, Williams-Ignarro S, Palagiano A, Crimi E, Ignarro LJ, Napoli C: Therapeutic dose of nebivolol, a nitric oxidereleasing beta-blocker, reduces atherosclerosis in cholesterol-fed rabbits. Nitric Oxide 2008; 19: 57-63.
16. Cayatte AJ, Palacino JJ, Horten K, Cohen RA: Chronic inhibition of nitric oxide production accelerates neointima formation and impairs endothelial function in hypercholesterolemic rabbits. Arterioscler Thromb 1994; 14: 753-759.
17. Knowles JW, Reddick RL, Jennette JC, Shesely EG, Smithies O, Maeda N: Enhanced atherosclerosis and kidney dysfunction in eNOS(-/-) Apoe(-/-) mice are ameliorated by enalapril treatment. J Clin Invest 2000; 105: 451-458. (Pubitemid 30127245)
18. Kuhlencordt PJ, Gyurko R, Han F, Scherrer- Crosbie M, Aretz TH, Hajjar R, Picard MH, Huang PL: Accelerated atherosclerosis, aortic aneurysm formation, and ischemic heart disease in apolipoprotein E/endothelial nitric oxide synthase double-knockout mice. Circulation 2001; 104: 448-454. (Pubitemid 32678276)
19. Napoli C, Ignarro LJ: Nitric oxide-releasing drugs. Annu Rev Pharmacol Toxicol 2003; 43: 97-123. (Pubitemid 37372636)
20. Bandarage UK, Janero DR: Nitric oxide-releasing nonsteroidal anti-inflammatory drugs: novel gastrointestinal-sparing drugs. Mini Rev Med Chem 2001; 1: 57-70.
21. Lavagna C, Del Soldato P, Burgaud JL, Rampal P: Nitric oxide-releasing non steroidal anti-inflammatory drugs: a new generation of anti-tumoral molecules. Curr Cancer Drug Targets 2003; 3: 407-426. (Pubitemid 38017478)
22. Napoli C, Ignarro LJ: Nitric oxide and atherosclerosis. Nitric Oxide 2001; 5: 88-97. (Pubitemid 34142732)
23. Institute of Laboratory Animal Resources, Commission on Life Sciences, National Research Council: Guide for the Care and Use of Laboratory Animals. Washington, National Academy Press, 1996.
24. Griess Reagent System: Instructions for the use of product G2930. Fitchburg, Promega Corp, 2009. http://www.promega.com/tbs/ tb229/tb229.pdf.
25. Gewaltig MT, Kojda G: Vasoprotection by nitric oxide: mechanisms and therapeutic potential. Cardiovasc Res 2002; 55: 250-260. (Pubitemid 34775275)
26. Cox JL, Chiasson DA, Gotlieb AI: Stranger in a strange land: the pathogenesis of saphenous vein graft stenosis with emphasis on structural and functional differences between veins and arteries. Prog Cardiovasc Dis 1991; 34: 45-68.
27. Thomas DD, Ridnour LA, Isenberg JS, Flores-Santana W, Switzer CH, Donzelli S, Hussain P, Vecoli C, Paolocci N, Ambs S, Colton CA, Harris CC, Roberts DD, Wink DA: The chemical biology of nitric oxide: implications in cellular signaling. Free Radic Biol Med 2008; 45: 18-31.
28. Balbatun A, Louka FR, Malinski T: Dynamics of nitric oxide release in the cardiovascular system. Acta Biochim Pol 2003; 50: 61-68. (Pubitemid 37034228)
29. Abbasi K, Sotudeh Anvari M, Mahdanian A, Ahmadi SH, Rabbani S, Karimi A, Marzban M, Shalileh K, Ashrafinia N: Atherosclerosis and vascular injury: the effect of a perivascular nitric oxide donor in a cholesterol-fed rabbit model. Ann Vasc Surg 2009; 23: 392-397.
30. Narayanaswamy M, Wright KC, Kandarpa K: Animal models for atherosclerosis, restenosis, and endovascular graft research. J Vasc Interv Radiol 2000; 11: 5-17. (Pubitemid 30067203)
31. Fitzhugh AL, Keefer LK: Diazeniumdiolates: pro- and antioxidant applications of the 'NONOates'. Free Radic Biol Med 2000; 28: 1463-1469. (Pubitemid 30604228)
32. Silastic MDX4-4210 biomedical grade elastomer with catalyst. Midland, Dow Corning Corporation, 2008. http://www.dowcorning. com/applications/search/ default.aspx?R= 187EN&DCCSF=333EN.
33. Mehta D, George SJ, Jeremy JY, Izzat MB, Southgate KM, Bryan AJ, Newby AC, Angelini GD: External stenting reduces long-term medial and neointimal thickening and platelet derived growth factor expression in a pig model of arteriovenous bypass grafting. Nat Med 1998; 4: 235-239. (Pubitemid 28137380)
34. Stefanadis C, Toutouzas K, Tsiamis E, Vlachopoulos C, Vaina S, Tsekoura D, Haldi L, Stefanadi E, Gravanis M, Toutouzas P: Stents covered by an autologous arterial graft in porcine coronary arteries: feasibility, vascular injury and effect on neointimal hyperplasia. Cardiovasc Res 1999; 41: 433-442. (Pubitemid 29087339)
35. Vijayan V, Shukla N, Johnson JL, Gadsdon P, Angelini GD, Smith FC, Baird R, Jeremy JY: Long-term reduction of medial and intimal thickening in porcine saphenous vein grafts with a polyglactin biodegradable external sheath. J Vasc Surg 2004; 40: 1011-1019. (Pubitemid 39535234)
36. Lucas MS, Moore DJ: Tissue culture and histologic study of a new elastomer. J Prosthet Dent 1979; 42: 447-451.